Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 4 5 6 7 8 9 10 11 12 13 14 15 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
03/08/2004	13h00	PR Newswire (US)	Allos Therapeutics Reports Second Quarter 2004 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/07/2004	15h00	PR Newswire (US)	Allos Therapeutics to Hold Q2 2004 Financial Results Conference Call and Webcast on Tuesday, August 3	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/06/2004	15h01	PR Newswire (US)	Allos Therapeutics Announces New Trade Names for Efaproxiral in the U.S. and Europe	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/06/2004	15h00	PR Newswire (US)	Allos to Present at Needham and Company's Third Annual Biotechnology Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/06/2004	15h01	PR Newswire (US)	Data Presented at ASCO Demonstrate That Red Blood Cell Levels of Allos Therapeutics' RSR13 Correlate With Treatment Effect in Pa	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/06/2004	20h05	PR Newswire (US)	Data From Phase 3 Trial of Allos Therapeutics' RSR13 (efaproxiral) Presented at ASCO	NASDAQ:ALTH
06/06/2004	19h23	PR Newswire (US)	Analysis From Phase 3 Trial Suggests That Some Non-Small Cell Lung Cancer Patients With Brain Metastases May Benefit From Allos	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/06/2004	15h00	PR Newswire (US)	Allos Therapeutics Files Application for European Marketing Approval of RSR13 (efaproxiral)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/06/2004	16h00	PR Newswire (US)	Federman & Sherwood Announces That a Securities Class Action Lawsuit Was Filed Against Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/06/2004	15h00	PR Newswire (US)	Allos Therapeutics Receives FDA Approvable Letter for RSR13 (efaproxiral)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/05/2004	15h00	PR Newswire (US)	Abstracts on Allos Therapeutics' RSR13 to Be Presented at American Society of Clinical Oncology Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/05/2004	18h23	PR Newswire (US)	Wolf Haldenstein Adler Freeman and Herz LLP Commences Class Action Lawsuit on Behalf of Allos Therapeutics, Inc. Shareholders	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/05/2004	23h13	PR Newswire (US)	Geller Rudman Announces Class Action Lawsuit Against Allos Therapeutics, Inc. on Behalf of Investors	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/05/2004	22h13	PR Newswire (US)	Shareholder Class Action Filed Against Allos Therapeutics, Inc. by the Law Firm of Schiffrin & Barroway, LLP	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/05/2004	00h00	PR Newswire (US)	Weinstein Kitchenoff Scarlato Karon & Goldman Ltd. Announces Class Action Lawsuit Against Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/05/2004	13h00	PR Newswire (US)	Allos Therapeutics Reports First Quarter 2004 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/05/2004	00h25	PR Newswire (US)	Allos Therapeutics to Hold Q1 2004 Financial Results Conference Call and Webcast on Thursday, May 6	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/05/2004	00h04	PR Newswire (US)	FDA Advisory Committee Does Not Recommend Approval of RSR13 as Adjunctive Therapy for the Treatment of Brain Metastases Originat	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/04/2004	23h30	PR Newswire (US)	Allos to Discuss ODAC Panel Recommendation on Monday May 3, 2004	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/03/2004	20h54	PR Newswire (US)	Allos NDA to be Reviewed by FDA Advisory Committee	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/03/2004	21h17	PR Newswire (US)	American Stock Exchange to Trade Options on Three Securities	NASDAQ:ALTH
06/03/2004	00h59	PR Newswire (US)	Allos Therapeutics Files Shelf Registration Statement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	13h45	PR Newswire (US)	Reminder - Allos Therapeutics Management Conference Call	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	13h00	PR Newswire (US)	Allos Begins Phase 3 Study of RSR13 in Women With Brain Metastases From Breast Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	12h00	PR Newswire (US)	Allos Therapeutics Reports Fourth Quarter and Year-End 2003 Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/12/2003	12h00	PR Newswire (US)	Allos Completes New Drug Application for Novel Treatment for Patients With Breast Cancer and Brain Metastases	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2003	23h30	PR Newswire (US)	Arizona Cancer Center Investigator Presents Positive Survival and Quality of Life Data From RSR13 Phase 3 Study	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/11/2003	13h00	PR Newswire (US)	Allos Therapeutics Announces RSR13 Phase 3 Results in Patients With Breast Cancer and Brain Metastases Will Be Highlighted at th	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/11/2003	23h24	PR Newswire (US)	Allos Therapeutics Completes $12 Million Private Placement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
18/11/2003	18h30	PR Newswire (US)	Allos Therapeutics Announces Presentation of Phase 1 Results of PDX in Patients With Advanced Non-Small Cell Lung Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)